{"id":50882,"date":"2014-09-01T13:19:57","date_gmt":"2014-09-01T13:19:57","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?p=50882"},"modified":"2023-09-06T10:29:47","modified_gmt":"2023-09-06T15:29:47","slug":"collection-audits","status":"publish","type":"post","link":"https:\/\/www.nationaldrugscreening.com\/blogs\/collection-audits\/","title":{"rendered":"Collection Audits"},"content":{"rendered":"\r\n
By Joe Reilly<\/a>, Past Chairman DATIA<\/p>\r\n\r\n\r\n\r\n Collection sites are often audited by FAA and FTA auditors and recently I have been retained by several regional and national collection site operators to provide audits of their company owned collection sites and mobile collections.\u00a0 Audits are a good thing because if you find out what your collectors are doing wrong, you can make the appropriate corrections and get the appropriate training completed so that your collectors eliminate mistakes that cause non-compliance and fatal flaws.<\/p>\r\n\r\n\r\n\r\n GOVERNMENT ACCOUNTABILITY OFFICE (GAO) 2007 UNDERCOVER INVESTIGATION FINDINGS<\/p>\r\n\r\n\r\n\r\n You might remember back in 2007 media exposure that exposed procedural errors in direct violation of the testing procedures defined in 49 CFR Part 40.\u00a0 An NBC Nightly News news story, aired on November 1, 2007, and reported the findings of a Government Accountability Office (GAO) undercover investigation that found it was surprisingly easy to cheat on random drug tests. The story was picked up by many other media outlets including FOX news. The news reports were aimed specifically at truck drivers.\u00a0 The box to the right lists a summary of those findings and in addition investigators used bogus identification to initiate the testing process in all (100%) of the 24 sites that were investigated demonstrating the ease at which safety-sensitive employees can send other (presumably drug-free) individuals to take the tests for them. Only two of the twenty-four sites followed all of the remainder of the testing procedures tested by the Investigators. The remaining twenty-two (91.7%) had two or more serious protocol violations.<\/p>\r\n\r\n\r\n\r\n Reviewing over 100 audits performed over the past 12 months, I am proud to say that collection sites are doing better but there are still issues that can certainly be corrected if collection site operators would pay more attention to DOT training requirements.\u00a0 Qualification training as a DOT specimen collector<\/a><\/strong> is not difficult to obtain, but it is also not a quick easy process for a new collector.\u00a0 When I train new collectors, there is a minimum 6 hour training process and mock collections always take at least two hours.<\/p>\r\n\r\n\r\n\r\n So what are we finding on current audits?\u00a0 You might be surprised at some of these findings.<\/p>\r\n\r\n\r\n\r\n As mentioned, still common in the specimen collection industry is the incorrect practice of filling out Step 4 of the CCF prior to starting the collection and pre dating the security seals.\u00a0 There are no shortcuts in the collection process, shortcuts lead to errors.\u00a0 The steps of the collection should be followed in order, and remember the DOT specimen collection order is 1, 2, 3, 5, and 4. \u00a0If the steps are filled out properly and in order, the percentage of mistakes that occur declines significantly.\u00a0 I cannot over emphasize the importance of taking your time with a collection and not taking short cuts; taking your leads to perfect collections.<\/p>\r\n\r\n\r\n\r\n The Federal Transit Administration (FTA)<\/strong> is particularly aggressive on collection audits.\u00a0 FTA maintains a full-fledged clandestine collection site inspection program.\u00a0 Reports from April 2014 from the FTA indicate that 10% of collection sites audited showed critical failures.\u00a0 Most common findings included not checking identity of donor, not checking pockets and not requiring hand washing. These are easily correctable errors, review these items with your collectors today.<\/p>\r\n\r\n\r\n\r\n Audits are occurring more and more.\u00a0 Several large collection services have begun doing internal audits.\u00a0 Of course the bottom line is proper training of collectors; and of course don\u2019t forget the DOT required refresher training and proficiency demonstration every five years.<\/p>\r\n\r\n\r\n\r\n Why is all of this so important?\u00a0 There are several reasons. We hear often that the collector or collection site is the weakest link in the drug testing process \u2013 lets change this.\u00a0Errors in the collection process can lead to issues with DOT regulators<\/strong><\/a> and the employer might be out of compliance facing fines and other sanctions.\u00a0 What about the donor, the employee who might have an erroneous test result reported due to an error?\u00a0 On the legal front, you certainly want all collections done properly and consistently \u2013 if not, you might face issues from a plaintiff\u2019s attorney on any challenge or law suit from a donor who tested positive and lost his or her job.<\/p>\r\n\r\n\r\n\r\n Without proper security and integrity in the collection process, donors have an opportunity to cheat on the test.\u00a0 This is a real safety issue as these same donors are driving on our public roads and may be under the influence of drugs or alcohol and undetected.<\/p>\r\n\r\n\r\n\r\n Employers should be monitoring the collection facilities or collectors that they hire to make sure collections are being performed correctly and collectors are not making the errors noted above.\u00a0 It is an employer\u2019s responsibility to make sure that the process is in compliance.\u00a0 I urge employers to not use collection facilities that are not up to speed and not doing collections properly.\u00a0 Ask your collectors about their training and about their procedures.\u00a0 Many collectors have not received the five year refresher training required by DOT and many have done collections that resulted in fatal flaws and not completed the required error correction training and proficiency demonstration.\u00a0 Employers and their Designated Employer Representatives (DER\u2019s) need to be proactive in monitoring the work performed by the service agents in the DOT drug testing program.<\/p>\r\n\r\n\r\n\r\n Collectors and collection site companies need to step up and make sure that the required training and refresher trainings are conducted by qualified trainers.\u00a0 There is no way this process can be learned by merely reading a pamphlet or watching a short video. \u00a0It is time to be proactive and eliminate and change the common phrase mentioned previously \u2013 collectors should not be the weakest link in the drug testing process.\u00a0 Qualified trainers should go through a train the trainer process like the DATIA Certified Professional Collector Trainer Program (CPCT).\u00a0 Don\u2019t have your existing collectors with bad habits train your new collectors.\u00a0<\/p>\r\n\r\n\r\n\r\n When errors occur, many times the donor will more than likely have to go back for another specimen collection; this will annoy both the donor and the employer \u2013 and the employer will not want to pay for the first collection which resulted in the fatal flaw. As collectors, we need to avoid all of these issues and do it right the first time \u2013 the key is training and refresher training and keeping up to date with the regulations.\u00a0 Look to DATIA, which is now the\u00a0National Drug & Alcohol Screening Association (NDASA)<\/a>, for a great resource for regulatory updates, training and promotion of the highest possible standards for the industry.<\/p>\r\n\r\n\r\n\r\n Joe Reilly entered the world of drug testing in 1993, he is well known throughout the industry and considered a leading expert on workplace drug testing issues. Joe served for nine years on the DATIA Board of Directors and served as Chairman of the Board from 2004\u20132008. Joe is currently a Regional Certified Professional Collector Trainer (RCPCT) for DATIA and is available for DATIA CPC training in all areas of Florida.\u00a0 He is also active in assisting buyers and sellers in the drug testing industry work through the merger and\/or acquisition process and provides various other consulting and training services.<\/em><\/p>\r\n","protected":false},"excerpt":{"rendered":" By Joe Reilly, Past Chairman DATIA Collection sites are often audited by FAA and FTA auditors and recently I have been retained by several regional and national collection site operators to provide audits of their company owned collection sites and mobile collections.\u00a0 Audits are a good thing because if you find out what your collectors […]<\/p>\n","protected":false},"author":12,"featured_media":51762,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/50882"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=50882"}],"version-history":[{"count":1,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/50882\/revisions"}],"predecessor-version":[{"id":118348,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/50882\/revisions\/118348"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/51762"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=50882"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=50882"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=50882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\r\n
\r\n